IP Library Granted Patent US 11,051,867
Granted Patent B2
US 11,051,867 · App. 15/755,523 · Granted Jul 6, 2021

Tissue contact verification system

Inventors: Alexei Babkin (Dana Point, CA); Meital Mazor (Laguna Hills, CA); Larry Varnado (Laguna Hills, CA)
Assignee: Adagio Medical, Inc.
A61B18/02A61B2017/00044A61B2018/00351A61B2018/00577A61B2018/00642A61B2018/00744A61B2018/00791A61B2018/00839A61B2018/00875A61B2018/0212A61B2018/0262A61B2090/065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,051,867
App. No.
15/755,523
Granted
Jul 6, 2021
Kind
B2
Abstract

A system for monitoring electrical activity at an ablation site where the system includes an ablation device having an elongate, flexible shaft and a distal treatment section for delivering ablation energy to target tissue, a first electrode mounted on the distal treatment section, a second electrode mounted on the distal treatment section where the second electrode is spaced from the first electrode a distance (D 1 ), a plurality of conducting elements extending along the distal treatment section and being connected to the first electrode and the second electrode, the plurality of conducting elements for connecting the first electrode and the second electrode to an electrophysiological recording system, a processing device programmed to receive the electrical information from the ablation site from the first electrode and the second electrode, and an electrophysiological recording system.

Claims (26)

1. A cryoablation system for creating a lesion in tissue, comprising:

a catheter comprising a flexible body and a distal treatment section, wherein the distal treatment section is adjustable from a substantially linear configuration to a curved configuration;

a plurality of electrodes on the distal treatment section; and

a console comprising a processor programmed to:

a) commence and terminate circulation of a cryogenic fluid through the distal treatment section for creating the lesion in the tissue;

b) monitor electrical activity from the plurality of electrodes on the distal treatment section;

c) calculate a tissue-contact value indicative of a length of the distal treatment section in direct contact with the tissue, based on the monitored electrical activity;

d) compute tissue freezing during circulation of the cryogenic fluid and tissue thawing based on the monitored electrical activity; and

e) confirm tissue necrosis subsequent to confirming tissue freezing based on the monitored electrical activity and

wherein the processor is further programmed to compute tissue thawing by comparing noise from the electrical activity to a threshold value.

2. The system of claim 1 , wherein the console is configured to receive electrocardiogram (ECG) signals based on the plurality of electrodes on the distal treatment section.

3. The system of claim 2 , wherein confirming tissue necrosis comprises comparing a pre-freeze ECG signal to a post-freeze ECG signal.

4. The system of claim 1 , wherein the console is further configured to send a current to at least one of the plurality of electrodes, and to acquire a total impedance value from the monitored electrical activity.

5. The system of claim 1 , wherein the console is further configured to send the tissue-contact value to a display.

6. The system of claim 1 , wherein the console is further configured to compute an image or beacon of the distal treatment section in direct contact with the target tissue.

7. The system of claim 1 , wherein the step of confirming necrosis comprises confirming pulmonary vein isolation.

8. The system of claim 1 , wherein the step of confirming necrosis comprises confirming cavo-tricuspid isthmus (CTI) bidirectional block.

9. The system of claim 1 , wherein the processor is further programmed to confirm whether the catheter is safe to move based on the monitored electrical activity.

10. The system of claim 1 , wherein the tissue comprises cardiac tissue.

11. The system of claim 1 , wherein the at least one electrode is formed of a continuous/junction-free electrically conducting material.

12. The system of claim 1 , wherein the at least one electrode is a band.

13. The system of claim 1 , wherein the at least one electrode is a plurality of pairs of electrodes.

14. The system of claim 1 , wherein the at least one electrode is at least one pair of electrodes for bipolar recording of electrical activity.

15. The system of claim 1 , wherein the distal treatment section is adjustable to form a line, ring or oval shape.

16. The system of claim 1 , wherein the electrical activity arises free of the Seebeck effect.

17. The system of claim 1 , wherein the cryogenic fluid is Nitrogen.

Assignments (2)
SECURITY INTEREST Recorded Jul 31, 2024
From: ADAGIO MEDICAL HOLDINGS, INC.
To: ALLEGRO MANAGEMENT LLC
Reel/Frame 068236/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2018
From: BABKIN, ALEXEI; MAZOR, MEITAL; VARNADO, LARRY
To: ADAGIO MEDICAL, INC.
Reel/Frame 046090/0262 →
Continuity (2)
Provisional Application 62220425 · Sep 18, 2015
Related Publication 20190125422A1 · May 2, 2019
Cited By (3)
US 12,290,370 US 12,336,804 US 12,367,958